A Novel Switchable CAR-T Platform for Acute Lymphoblastic Leukemia Treatment

被引：0
|
作者：
Laborda, Eduardo
Hampton, Eric N.
Lee, Sung C.
Woods, Ashley K.
Young, Travis S.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3890
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A novel switchable car-T cell therapy for tumor retargeting and improved safety
    Castellarin, M.
    Sands, C.
    Young, R.
    June, C.
    [J]. CYTOTHERAPY, 2020, 22 (05) : S18 - S19
  • [42] Dasatinib and CAR-T Cell Therapy for Newly Diagnosed Ph-Positive Acute Lymphoblastic Leukemia in Adults
    Zhang, Mingming
    Hu, Yongxian
    Wei, Guoqing
    Fu, Shan
    Feng, Jingjing
    Hong, Ruimin
    Chang, Alex H.
    Huang, He
    [J]. BLOOD, 2023, 142
  • [43] CAR-T Cell Therapy-Related Neurotoxicity in Pediatric Acute Lymphoblastic Leukemia: Spectrum of Imaging Findings
    Tan, Ai Peng
    [J]. PEDIATRIC NEUROLOGY, 2020, 111 : 51 - 58
  • [44] Corticosteroids Do Not Influence the Efficacy and Kinetics of CAR-T Cells for B-Cell Acute Lymphoblastic Leukemia
    Liu, Shuangyou
    Deng, Biping
    Pan, Jing
    Yin, Zhichao
    Lin, Yuehui
    Ling, Zhuojun
    Wu, Tong
    Gao, Zhiyong
    Song, Yanzhi
    Zhao, Yongqiang
    Tong, Chunrong
    [J]. BLOOD, 2019, 134
  • [45] Acute lymphoblastic leukemia: From aminopterin to CAR T cells
    Ribera Santasusana, Josep-Maria
    [J]. MEDICINA CLINICA, 2020, 154 (07): : 269 - 274
  • [46] Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia
    Xian Zhang
    Junfang Yang
    Jingjing Li
    Wenqian Li
    Dan Song
    Xin-an Lu
    Fei Wu
    Jianqiang Li
    Dandan Chen
    Xiangqun Li
    Zhongwei Xu
    Shuqiang Liu
    Ziyu Li
    Kui Ying
    Peihua Lu
    [J]. Cancer Immunology, Immunotherapy, 2022, 71 : 689 - 703
  • [47] CLBR001+SWI019: A novel switchable CAR-T cell platform enabling functionally reversible on/off control of CAR-T cell activity for B cell malignancies.
    Young, Travis
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [48] Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia
    Zhang, Xian
    Yang, Junfang
    Li, Jingjing
    Li, Wenqian
    Song, Dan
    Lu, Xin-An
    Wu, Fei
    Li, Jianqiang
    Chen, Dandan
    Li, Xiangqun
    Xu, Zhongwei
    Liu, Shuqiang
    Li, Ziyu
    Ying, Kui
    Lu, Peihua
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (03) : 689 - 703
  • [49] Pre-Clinical Activity of Allogeneic AntiCD22 CAR-T Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
    Wells, Julia
    Cai, Tianyu
    Schiffer-Manniou, Cecile
    Filipe, Stephanie
    Gouble, Agnes
    Galetto, Roman
    Jain, Nitin
    Jabbour, Elias J.
    Smith, Julianne
    Konopleva, Marina
    [J]. BLOOD, 2017, 130
  • [50] Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy
    Kong, Delin
    Yang, Tingting
    Geng, Jia
    Jing, Ruirui
    Zhang, Qiqi
    Wei, Guoqing
    Huang, He
    Hu, Yongxian
    [J]. JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2022, 23 (10): : 876 - 880
12345